Editorial: PDF OnlyIs This the Beginning of the End of Cytokine Adsorption?Kielstein, Jan T. MD1; Zarbock, Alexander MD, PhD2 Author Information 1 Medical Clinic V, Nephrology | Rheumatology | Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany 2 Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany Drs. Kielstein and Zarbock wrote the article. Dr. Kielstein analyzed the data of the Statistische Bundesamt on CytoSorb treatments in Germany. Dr. Kielstein was funded by intramural grants. Dr. Zarbock received grants from the German Research Foundation (KFO342-1, ZA428/18-1, and ZA428/21-1 to Dr. Zarbock). Dr. Kielstein received research grants from ExThera Medical and speaker fees from Fresenius Medical Care. Dr. Zarbock’s institution received funding from Astute Medical, Baxter, Fresenius, Astellas Medical, BioMereiux, Bayer, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, and German-Israeli Foundation; he received funding from Novartis, AM Pharma, Guard Therapeutics, Paion, La Jolla Pharmaceuticals, Baxter, Fresenius, Astellas Medial, BioMereiux, and Bayer. Critical Care Medicine: February 21, 2022 - Volume - Issue - doi: 10.1097/CCM.0000000000005509 Buy PAP Metrics Copyright © by 2022 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.